Close X
Wednesday, October 2, 2024
ADVT 
National

Bombardier stock plunges in heavy trading amid revised Aerospace outlook

Darpan News Desk The Canadian Press, 15 Jan, 2015 10:19 AM

    MONTREAL — Bombardier stock plunged in heavy trading Thursday following a revised outlook for its aerospace business, including plans to put development of the Learjet 85 business jet on hold due to weak customer interest — a move that will result in the elimination of 1,000 jobs in the United States and Mexico.

    The Montreal-based company's shares were down about 20 per cent with an unusually heavy 25.5 million traded before noon on the Toronto Stock Exchange. The stock dropped to a multi-year of $3, down about 25 per cent from the previous close of $4.14 before the company's early-morning announcement.

    The aerospace and rail equipment manufacturer said before markets opened that it will "pause" development of the Learjet 85, but continue to sell other models and focus on two other aircraft programs — the Global 7000/8000 business jet and the CSeries passenger jet for commercial airlines.

    Bombardier also trimmed its 2015 guidance, including a significant drop in the amount of cash flow it expects from its aerospace division. At least one analyst said this raised the possibility that Bombardier may resort to selling stock to improve its financial cushion — a move that would be negative for current shareholders.

    The new cashflow estimate for Bombardier Aerospace is US$800 million, down from the previous estimate of between US$1.2 billion to US$$1.6 billion in the prior forecast. Cash flow from the rail division is expected to increase slightly.

    David Tyerman of Canaccord Genuity said the credibility of Bombardier's management is likely to take a major hit from Thursday's announcement.

    "We already perceive that investors have a poor opinion of management and this will likely make it worse. It also will likely lessen investor/analyst confidence in management's forward looking guidance. We regard this as a major issue with potential negative implications for the company's valuation multiple," Tyerman wrote in a report.

    He added that the company could breach its minimum short-term liquidity threshold of US$3 billion, raising the risk of it issuing more shares.

    Bombardier's decision to shelve the Learjet 85 and to cut jobs follows last year's elimination of 2,900 positions around the world — 2,000 non-union administrative jobs at Bombardier Aerospace and 900 at Bombardier Transportation, the company's rail equipment division.

    Bombardier (TSX:BBD.B) said Thursday will also write down the value of its Learjet 85 program, resulting in a pretax charge of about US$1.4 billion in the company's fourth quarter.

    The company will also record US$25 million for severance in its first quarter of 2015.

    Bombardier said its operations in Wichita, Kansas and Queretaro, Mexico remain important to the company for both the Learjet and other types of aircraft that it makes.

    The Wichita operation does final assembly for Learjet 70 and Learjet 75 aircraft and has a flight test centre and service centre.

    The Queretaro operation makes a major component for the Global 7000 and 8000 business jets.

    Bombardier also trimmed its 2015 guidance, reducing its pre-tax operating earnings (EBIT) outlook for aerospace and transportation by one percentage point — to four and six per cent respectively.

    The aerospace cut was due to lower customer advances, pricing pressure on new aircraft sold, lower fair value for used aircraft and reduced assumptions for some railway contracts._

    As of Dec. 31, Bombardier has US$3.8 billion in available finances, including about US$2.4 billion cash and equivalents.

    Cameron Doerksen of National Bank Financial said the Learjet 85 pause will have an impact on companies like Heroux-Devtek (TSX:HRX), which is developing landing gear for the plane.

    He added that a delay in the business jet program was widely anticipated and could have a $10 million impact on Heroux in fiscal 2018.

    MORE National ARTICLES

    Mounties charge Ottawa man with breaking federal Lobbying Act

    Mounties charge Ottawa man with breaking federal Lobbying Act
    OTTAWA - The Mounties have charged an Ottawa man with breaking the federal Lobbying Act.

    Mounties charge Ottawa man with breaking federal Lobbying Act

    Residents of small Alberta town to vote in plebiscite to allow alcohol sales

    Residents of small Alberta town to vote in plebiscite to allow alcohol sales
    CARDSTON, Alta. - A ban on alcohol sales that has been in place since Alberta became a province will be voted on in a plebiscite in the town of Cardston today.

    Residents of small Alberta town to vote in plebiscite to allow alcohol sales

    John O'Keefe, May-Britt Moser and Edvard Moser win Nobel Prize in medicine for brain GPS

    John O'Keefe, May-Britt Moser and Edvard Moser win Nobel Prize in medicine for brain GPS
    STOCKHOLM - U.S.-British scientist John O'Keefe and Norwegian scientists May-Britt Moser and Edvard Moser won the Nobel Prize in medicine on Monday for discovering the "inner GPS" that helps the brain navigate through the world.

    John O'Keefe, May-Britt Moser and Edvard Moser win Nobel Prize in medicine for brain GPS

    Today on the Hill: Parliament debates Harper government plan for Iraq

    Today on the Hill: Parliament debates Harper government plan for Iraq
    OTTAWA - Members of Parliament debate a motion today that will send Canada to war in Iraq — should it pass as widely expected.

    Today on the Hill: Parliament debates Harper government plan for Iraq

    Magnotta jury hears police don't know how, when or why he and Jun Lin first met

    Magnotta jury hears police don't know how, when or why he and Jun Lin first met
    MONTREAL - The jury in Luka Rocco Magnotta's first-degree murder trial has been told that police were not able to establish how, when or why the accused first met his future victim, Jun Lin.

    Magnotta jury hears police don't know how, when or why he and Jun Lin first met

    Experts starting to admit it may take vaccine to stop Ebola in West Africa

    Experts starting to admit it may take vaccine to stop Ebola in West Africa
    TORONTO - As West Africa's Ebola outbreak continues to rage, some experts are coming to the conclusion that it may take large amounts of vaccines and maybe even drugs — all still experimental and in short supply — to bring the outbreak under control.

    Experts starting to admit it may take vaccine to stop Ebola in West Africa